New Darzalex formulation wins FDA approval; Israeli biotech plans $50M IPO
→ During the Covid-19 crisis, drugs that must be administered in hospital settings or take hours to be infused are seeing delayed uptake as health …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
